Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07825688 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TxAccess and Dd-cfDNA for Improved Care of Patients With Delayed Graft Function

Name: TxAccess and Dd-cfDNA for Improved Care of Patients With Delayed Graft Function — clinical trial record (NCT07825688)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhaseNot applicable

SponsorDuke University

Started2026-09-15

View on ClinicalTrials.gov ↗

Duke University

455 trials monitored

See 53 trials at risk

This is a prospective multicenter nonrandomized pragmatic hybrid effectiveness-implementation study to test the effectiveness of TxAccess in improving time to renal recovery and immunologic outcomes in patients with delayed graft function (DGF) and to assess barriers and facilitators to implementation of TxAccess in the post-transplant care period. Research blood will be collected for donor-derived cell-free DNA testing, and patient questionnaires will be administered.

Trial Details

NCT Number	NCT07825688
Lead Sponsor	Duke University Collaborators: CareDx, Inc.
Conditions	Delayed Graft Function
Enrollment	450 participants
Start Date	2026-09-15
Primary Completion	2029-01-31 (estimated)
Study Completion	2029-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-09-17